CPHI vs KIM · rev $4.1M vs P/E 27, $16.03B cap
China Pharma Holdings Inc (CPHI) versus Kimco Realty Corporation (KIM) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Kimco Realty Corporation (KIM) is a reit - retail company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
KIM does not have a complete income-statement cache yet.
CPHI currently screens at market cap $29.0M. KIM currently screens at market cap $16.03B and trailing P/E 27.3.
Not investment advice. Open the CPHI and KIM stock pages for the full models.
Not investment advice.